Clinical and transcriptomic features of persistent exacerbation-prone severe asthma in U-BIOPRED cohort.

Hoda, Uruj; Pavlidis, Stelios; Bansal, Aruna T; Takahashi, Kentaro; Hu, Sile; Ng Kee Kwong, Francois; Rossios, Christos; Sun, Kai; Bhavsar, Pankaj; Loza, Matthew; Baribaud, Frederic; Chanez, Pascal; Fowler, Stephen J; Horvath, Ildiko; Montuschi, Paolo; Singer, Florian; Musial, Jacek; Dahlen, Barbro; Krug, Norbert; Sandstrom, Thomas; ... (2022). Clinical and transcriptomic features of persistent exacerbation-prone severe asthma in U-BIOPRED cohort. Clinical and translational medicine, 12(4), e816. 10.1002/ctm2.816

[img]
Preview
Text
Clinical_Translational_Med_-_2022_-_Hoda_-_Clinical_and_transcriptomic_features_of_persistent_exacerbation_prone_severe.pdf - Published Version
Available under License Creative Commons: Attribution (CC-BY).

Download (1MB) | Preview

BACKGROUND

Exacerbation-prone asthma is a feature of severe disease. However, the basis for its persistency remains unclear.

OBJECTIVES

To determine the clinical and transcriptomic features of frequent exacerbators (FEs) and persistent FEs (PFEs) in the U-BIOPRED cohort.

METHODS

We compared features of FE (≥2 exacerbations in past year) to infrequent exacerbators (IE, <2 exacerbations) and of PFE with repeat ≥2 exacerbations during the following year to persistent IE (PIE). Transcriptomic data in blood, bronchial and nasal epithelial brushings, bronchial biopsies and sputum cells were analysed by gene set variation analysis for 103 gene signatures.

RESULTS

Of 317 patients, 62.4% had FE, of whom 63.6% had PFE, while 37.6% had IE, of whom 61.3% had PIE. Using multivariate analysis, FE was associated with short-acting beta-agonist use, sinusitis and daily oral corticosteroid use, while PFE was associated with eczema, short-acting beta-agonist use and asthma control index. CEA cell adhesion molecule 5 (CEACAM5) was the only differentially expressed transcript in bronchial biopsies between PE and IE. There were no differentially expressed genes in the other four compartments. There were higher expression scores for type 2, T-helper type-17 and type 1 pathway signatures together with those associated with viral infections in bronchial biopsies from FE compared to IE, while there were higher expression scores of type 2, type 1 and steroid insensitivity pathway signatures in bronchial biopsies of PFE compared to PIE.

CONCLUSION

The FE group and its PFE subgroup are associated with poor asthma control while expressing higher type 1 and type 2 activation pathways compared to IE and PIE, respectively.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Gynaecology, Paediatrics and Endocrinology (DFKE) > Clinic of Paediatric Medicine
04 Faculty of Medicine > Department of Gynaecology, Paediatrics and Endocrinology (DFKE) > Clinic of Paediatric Medicine > Paediatric Pneumology

UniBE Contributor:

Singer, Florian

Subjects:

600 Technology > 610 Medicine & health

ISSN:

2001-1326

Language:

English

Submitter:

Anette van Dorland

Date Deposited:

28 Apr 2022 13:26

Last Modified:

20 Jul 2022 16:29

Publisher DOI:

10.1002/ctm2.816

PubMed ID:

35474304

Uncontrolled Keywords:

CEACAM5 asthma exacerbations frequent exacerbators persistent frequent exacerbators severe asthma

BORIS DOI:

10.48350/169584

URI:

https://boris.unibe.ch/id/eprint/169584

Actions (login required)

Edit item Edit item
Provide Feedback